Sage Journals: Discover world-class research

Open access

Research article

First published 2024

Cost-effectiveness analysis of durvalumab plus tremelimumab as first-line therapy in patients with unresectable hepatocellular carcinoma

Weiting Liao, Huiqiong Xu, David Hutton [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2025

Tremelimumab Plus Durvalumab in Advanced Hepatocellular Carcinoma Treatment: A Pharmacovigilance Comparative Analysis Between Eudravigilance and HIMALAYA Study

Eleonora Castellana, Patricia Madalina Budau, Maria Rachele Chiappetta

Hospital Pharmacy

Retricted access

Research article

First published 2014-4

HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid Haemorrhage with Secondary IschaemiA): A Randomized Single-Blind Controlled Trial of Induced Hypertension vs. no Induced Hypertension in the Treatment of Delayed Cerebral Ischemia after Subarachnoid Hemorrhage

C. S. Gathier, W. M. van den Bergh, A. J. C. Slooter [...]

International Journal of Stroke

Open access

Review article

First published 2022

Frontline therapy for advanced hepatocellular carcinoma: an update

Mehmet Akce, Bassel F. El-Rayes, Tanios S. Bekaii-Saab

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2011-3

Spironolactone Does Not Prevent Acute Mountain Sickness: A Prospective,Double-Blind,Randomized,Placebo-Controlled Trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group)

Buddha Basnyat, Peter S. Holck, Matiram Pun [...]

Wilderness & Environmental Medicine

Free access

Research article

First published 2010-9

Prospective,Double-Blind,Randomized,Placebo-Controlled Comparison of Acetazolamide Versus Ibuprofen for Prophylaxis Against High Altitude Headache: The Headache Evaluation at Altitude Trial (HEAT)

Jeffrey H. Gertsch, Grant S. Lipman, Peter S. Holck [...]

Wilderness & Environmental Medicine

Retricted access

Research article

First published 2006-03

Acetazolamide 125 mg BD Is Not Significantly Different from 375 mg BD in the Prevention of Acute Mountain Sickness: The Prophylactic Acetazolamide Dosage Comparison for Efficacy (PACE) Trial

Buddha Basnyat, Jeffrey H. Gertsch, Peter S. Holck [...]

High Altitude Medicine & Biology

Retricted access

Research article

First published 2015-06

Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID)

Grant S. Lipman, Nicholas C. Kanaan, Caleb Phillips [...]

High Altitude Medicine & Biology

Search results